| 000 | 01687 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516075824.0 | ||
| 264 | 0 | _c20121126 | |
| 008 | 201211s 0 0 chi d | ||
| 022 | _a0253-3766 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Lin-Wei | |
| 245 | 0 | 0 |
_a[Mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) gene expression in esophageal squamous cell carcinoma cell line EC9706]. _h[electronic resource] |
| 260 |
_bZhonghua zhong liu za zhi [Chinese journal of oncology] _cAug 2011 |
||
| 300 |
_a570-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xpharmacology |
| 650 | 0 | 4 |
_aAzacitidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCpG Islands _xgenetics |
| 650 | 0 | 4 | _aDNA Methylation |
| 650 | 0 | 4 | _aDecitabine |
| 650 | 0 | 4 | _aEpigenesis, Genetic |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xgenetics |
| 650 | 0 | 4 | _aExons |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aOxides _xpharmacology |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aTumor Suppressor Proteins |
| 700 | 1 | _aYu, Xi-Ying | |
| 700 | 1 | _aLi, Xiao-Yan | |
| 700 | 1 | _aGuo, Li-Ping | |
| 700 | 1 | _aZhou, Yun | |
| 700 | 1 | _aLu, Shi-Xin | |
| 773 | 0 |
_tZhonghua zhong liu za zhi [Chinese journal of oncology] _gvol. 33 _gno. 8 _gp. 570-3 |
|
| 999 |
_c21536543 _d21536543 |
||